'Some biotech firms will not survive': Layoffs, closures, and mergers expected as part of an industry 'correction' - The Boston Globe

After years of unchecked growth, biotech companies with little cash on hand after 14 months of deflated stock prices could soon resort to layoffs or mergers in an effort to stay alive.

At the same time, investments from venture capital firms in Massachusettsbiotech startups reached a record high in 2021. And technologies such as mRNA vaccines and CRISPR gene editing have cemented C… [+6922 chars]

full article...